DNA Analysis in Prostate Cancer for Prognosis and Treatment Response
Author Information
Author(s): T. Visakorpi, O.-P. Kallioniemi, I.Y.I. Paronen, J.J. Isola, A.I. Heikkinen, T.A. Koivula
Primary Institution: Tampere University Hospital
Hypothesis
Does DNA ploidy and S-phase fraction (SPF) in prostatic carcinomas correlate with prognosis and response to endocrine therapy?
Conclusion
High S-phase fraction in prostate cancer may indicate poor prognosis and lack of hormonal responsiveness.
Supporting Evidence
- DNA aneuploidy and high S-phase fraction were associated with high tumor grade and presence of distant metastases.
- Patients with high S-phase fraction had significantly shorter overall survival rates.
- None of the tumors with S-phase fraction above 12% showed a response to endocrine therapy.
Takeaway
This study looked at how the DNA of prostate cancer cells can help doctors understand how aggressive the cancer is and how well it might respond to treatment.
Methodology
Flow cytometry was used to analyze DNA ploidy and S-phase fraction from paraffin-embedded primary prostatic carcinomas.
Limitations
The study had a small sample size and did not account for all potential confounding factors.
Participant Demographics
Patients diagnosed with primary prostatic carcinomas at Tampere University Central Hospital between 1977-1979.
Statistical Information
P-Value
P = 0.0002
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website